|
Neuroprotectors
Citations 101-110 of 537 total displayed.
|
Past content
(since Jan 1999):
|
- Original Contributions
Soluble Epoxide Hydrolase Gene Deletion Is Protective Against Experimental Cerebral Ischemia
- Wenri Zhang, Takashi Otsuka, Nobuo Sugo, Ardi Ardeshiri, Yazan K. Alhadid, Jeffrey J. Iliff, Andrea E. DeBarber, Dennis R. Koop, and Nabil J. Alkayed
Stroke 2008;39:2073-2078; published online before print as doi:10.1161/STROKEAHA.107.508325
[Abstract]
[Full text]
- Original Contributions
Strong Neuroprotection by Inhibition of NF- B After Neonatal Hypoxia-Ischemia Involves Apoptotic Mechanisms but Is Independent of Cytokines
- Cora H.A. Nijboer, Cobi J. Heijnen, Floris Groenendaal, Michael J. May, Frank van Bel, and Annemieke Kavelaars
Stroke 2008;39:2129-2137; published online before print as doi:10.1161/STROKEAHA.107.504175
[Abstract]
[Full text]
- Editorials
Is It Time to Definitely Abandon Neuroprotection in Acute Ischemic Stroke?
- Maria Luisa Sacchetti
Stroke 2008;39:1659-1660; published online before print as doi:10.1161/STROKEAHA.107.505024
[Full text]
- Original Contributions
NXY-059 for the Treatment of Acute Stroke: Pooled Analysis of the SAINT I and II Trials
- Hans-Christoph Diener, Kennedy R. Lees, Patrick Lyden, Jim Grotta, Antoni Davalos, Stephen M. Davis, Ashfaq Shuaib, Tim Ashwood, Warren Wasiewski, Vivian Alderfer, Hans-Goran Hårdemark, Larry Rodichok for the SAINT I and II Investigators
Stroke 2008;39:1751-1758; published online before print as doi:10.1161/STROKEAHA.107.503334
[Abstract]
[Full text]
- Original Contributions
DP-b99, a Membrane-Activated Metal Ion Chelator, as Neuroprotective Therapy in Ischemic Stroke
- Hans-Christoph Diener, Dietmar Schneider, Yair Lampl, Natan M. Bornstein, Alexander Kozak, Gilad Rosenberg on Behalf of the Study Group
Stroke 2008;39:1774-1778; published online before print as doi:10.1161/STROKEAHA.107.506378
[Abstract]
[Full text]
- Original Contributions
Meta-Analysis of the Efficacy of Granulocyte-Colony Stimulating Factor in Animal Models of Focal Cerebral Ischemia
- Jens Minnerup, Jan Heidrich, Jürgen Wellmann, Andreas Rogalewski, Armin Schneider, and Wolf-Rüdiger Schäbitz
Stroke 2008;39:1855-1861; published online before print as doi:10.1161/STROKEAHA.107.506816
[Abstract]
[Full text]
- Original Contributions
Effects of Neuroglobin Overexpression on Acute Brain Injury and Long-Term Outcomes After Focal Cerebral Ischemia
- Xiaoying Wang, Jianxiang Liu, Haihao Zhu, Emiri Tejima, Kiyoshi Tsuji, Yoshihiro Murata, Dmitriy N. Atochin, Paul L. Huang, Chenggang Zhang, and Eng H. Lo
Stroke 2008;39:1869-1874; published online before print as doi:10.1161/STROKEAHA.107.506022
[Abstract]
[Full text]
- Original Contributions
Albumin Therapy Augments the Effect of Thrombolysis on Local Vascular Dynamics in a Rat Model of Arteriolar Thrombosis: A Two-Photon Laser-Scanning Microscopy Study
- Hee-Pyoung Park, Anitha Nimmagadda, Richard A. DeFazio, Raul Busto, Ricardo Prado, and Myron D. Ginsberg
Stroke 2008;39:1556-1562; published online before print as doi:10.1161/STROKEAHA.107.502195
[Abstract]
[Full text]
- Articles
A Dual Role of the NF-B Pathway in Neonatal Hypoxic-Ischemic Brain Damage
- Cora H. Nijboer, Cobi J. Heijnen, Floris Groenendaal, Michael J. May, Frank van Bel, and Annemieke Kavelaars
Stroke published April 17, 2008, doi:10.1161/STROKEAHA.108.516401
[Abstract]
- Articles
Strong Neuroprotection by Inhibition of NF-B After Neonatal Hypoxia-Ischemia Involves Apoptotic Mechanisms but Is Independent of Cytokines
- Cora H.A. Nijboer, Cobi J. Heijnen, Floris Groenendaal, Michael J. May, Frank van Bel, and Annemieke Kavelaars
Stroke published April 17, 2008, doi:10.1161/STROKEAHA.107.504175
[Abstract]
|
|
